{"title":"探索医疗保健领域可穿戴生物传感器的技术驱动型技术路线图 (TRM)","authors":"Yu-Hui Wang","doi":"10.1016/j.irbm.2024.100835","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>This paper is proposed to identify both promising technologies and potential products in the domain of biosensor using patent-based Technology-Driven Technology Roadmaps (TRM).</p></div><div><h3>Materials and methods</h3><p>The technology-driven TRM with timelines in this study is developed in three layers: technology, function and product. Patent applications are collected and identified to interpret technologies and functions for biosensors in healthcare, and product manuals or releases can be used as product introductions.</p></div><div><h3>Results</h3><p>Most biosensors in healthcare patents are concentrated in biochemical (T2) and electroencephalography (T5). Glycated hemoglobin (F1), measuring of glucose (F3), and biological process and molecular systems (F6) have a relatively larger patent count. Biochemical (T2) can combine with biological process and molecular systems (F6), and then brain's real-time electrical activity monitoring can be handled. Biochemical (T2) can also devote to glycated hemoglobin (F1), and glucose monitoring (F3), and thus create QCM sensor, CGM and GlucoWatch etc. applications.</p></div><div><h3>Conclusion</h3><p>Biochemical (T2) has a wide application among different functions for wearable biosensors in healthcare. This paper identifies and explores new developments biochemical (T2), and electroencephalography (T5) in wearable biosensors are expected to play a significant role over the coming decade in improving the current healthcare infrastructure, and enhancing the democratization of information and allocation of medical resources.</p></div>","PeriodicalId":14605,"journal":{"name":"Irbm","volume":null,"pages":null},"PeriodicalIF":5.6000,"publicationDate":"2024-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exploring Technology-Driven Technology Roadmaps (TRM) for Wearable Biosensors in Healthcare\",\"authors\":\"Yu-Hui Wang\",\"doi\":\"10.1016/j.irbm.2024.100835\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>This paper is proposed to identify both promising technologies and potential products in the domain of biosensor using patent-based Technology-Driven Technology Roadmaps (TRM).</p></div><div><h3>Materials and methods</h3><p>The technology-driven TRM with timelines in this study is developed in three layers: technology, function and product. Patent applications are collected and identified to interpret technologies and functions for biosensors in healthcare, and product manuals or releases can be used as product introductions.</p></div><div><h3>Results</h3><p>Most biosensors in healthcare patents are concentrated in biochemical (T2) and electroencephalography (T5). Glycated hemoglobin (F1), measuring of glucose (F3), and biological process and molecular systems (F6) have a relatively larger patent count. Biochemical (T2) can combine with biological process and molecular systems (F6), and then brain's real-time electrical activity monitoring can be handled. Biochemical (T2) can also devote to glycated hemoglobin (F1), and glucose monitoring (F3), and thus create QCM sensor, CGM and GlucoWatch etc. applications.</p></div><div><h3>Conclusion</h3><p>Biochemical (T2) has a wide application among different functions for wearable biosensors in healthcare. This paper identifies and explores new developments biochemical (T2), and electroencephalography (T5) in wearable biosensors are expected to play a significant role over the coming decade in improving the current healthcare infrastructure, and enhancing the democratization of information and allocation of medical resources.</p></div>\",\"PeriodicalId\":14605,\"journal\":{\"name\":\"Irbm\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2024-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Irbm\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1959031824000162\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Irbm","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1959031824000162","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Exploring Technology-Driven Technology Roadmaps (TRM) for Wearable Biosensors in Healthcare
Objectives
This paper is proposed to identify both promising technologies and potential products in the domain of biosensor using patent-based Technology-Driven Technology Roadmaps (TRM).
Materials and methods
The technology-driven TRM with timelines in this study is developed in three layers: technology, function and product. Patent applications are collected and identified to interpret technologies and functions for biosensors in healthcare, and product manuals or releases can be used as product introductions.
Results
Most biosensors in healthcare patents are concentrated in biochemical (T2) and electroencephalography (T5). Glycated hemoglobin (F1), measuring of glucose (F3), and biological process and molecular systems (F6) have a relatively larger patent count. Biochemical (T2) can combine with biological process and molecular systems (F6), and then brain's real-time electrical activity monitoring can be handled. Biochemical (T2) can also devote to glycated hemoglobin (F1), and glucose monitoring (F3), and thus create QCM sensor, CGM and GlucoWatch etc. applications.
Conclusion
Biochemical (T2) has a wide application among different functions for wearable biosensors in healthcare. This paper identifies and explores new developments biochemical (T2), and electroencephalography (T5) in wearable biosensors are expected to play a significant role over the coming decade in improving the current healthcare infrastructure, and enhancing the democratization of information and allocation of medical resources.
期刊介绍：
IRBM is the journal of the AGBM (Alliance for engineering in Biology an Medicine / Alliance pour le génie biologique et médical) and the SFGBM (BioMedical Engineering French Society / Société française de génie biologique médical) and the AFIB (French Association of Biomedical Engineers / Association française des ingénieurs biomédicaux).
As a vehicle of information and knowledge in the field of biomedical technologies, IRBM is devoted to fundamental as well as clinical research. Biomedical engineering and use of new technologies are the cornerstones of IRBM, providing authors and users with the latest information. Its six issues per year propose reviews (state-of-the-art and current knowledge), original articles directed at fundamental research and articles focusing on biomedical engineering. All articles are submitted to peer reviewers acting as guarantors for IRBM''s scientific and medical content. The field covered by IRBM includes all the discipline of Biomedical engineering. Thereby, the type of papers published include those that cover the technological and methodological development in:
-Physiological and Biological Signal processing (EEG, MEG, ECG…)-
Medical Image processing-
Biomechanics-
Biomaterials-
Medical Physics-
Biophysics-
Physiological and Biological Sensors-
Information technologies in healthcare-
Disability research-
Computational physiology-
…
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
